Research and Markets (http://www.researchandmarkets.com/research/hrbwxl/ireland_in_vitro) has announced the addition of Global Markets Direct's new report "Ireland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018" to their offering.
Global Markets Direct's new report, Ireland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Ireland In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.
Scope
- Market size and company share data for In Vitro Diagnostics market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the twelve market categories.
- Global corporate-level profiles of key companies operating within the Ireland In Vitro Diagnostics market.
Companies Mentioned
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Siemens Healthcare
Ortho-Clinical Diagnostics Inc.
Beckman Coulter, Inc.
bioMerieux S.A.
Sysmex Corporation
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company
Qiagen N.V.
DiaSorin S.p.A
Alere Inc.
Thermo Fisher Scientific Inc.
PerkinElmer, Inc.
Diagnostica Stago, Inc.
Gen-Probe Incorporated
Horiba, Ltd.
Immucor, Inc.
Life Technologies Corporation
Grifols, S.A.
Hologic, Inc.
Danaher Corporation
Phadia AB
For more information visit http://www.researchandmarkets.com/research/hrbwxl/ireland_in_vitro
Source: Global Markets Direct
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In
Vitro Diagnostics
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.